Stocks-ABT-Abbott Laboratories

ABT Abbott Laboratories

114.00 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Abbott Laboratories's revenues decreased by 8.12% and amounted to 40.11B. Net income decreased by 17.45% to 5.72B. Net assets decreased by NaN to N/A and EPS decreased from 3.93 to 3.27.
ABT's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
57.17%
Net Profit Margin
14.16%
Operating Margin
16.03%
Return On Investment
10.59%